The ratio of CD34+CD117dim population, first identified in the t (8;21) AML subtype, were proved to be associated with the disease clinical outcome and were efficient in stratifying the patients when combined with KIT mutations in t (8;21) AML. Here, CD34 is linked to acute myeloid leukemia.